2023 Q3 Form 10-Q Financial Statement

#000138584923000031 Filed on August 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $10.99M $6.863M $6.467M
YoY Change 274.6% 6.12% 1318.2%
Cost Of Revenue $5.548M $4.367M $3.419M
YoY Change 262.85% 27.73%
Gross Profit $5.439M $2.496M $3.048M
YoY Change 287.39% -18.11% 568.42%
Gross Profit Margin 49.5% 36.37% 47.13%
Selling, General & Admin $7.304M $7.458M $4.703M
YoY Change 3.24% 58.58% 23.37%
% of Gross Profit 134.29% 298.8% 154.3%
Research & Development $2.520M $3.820M $1.220M
YoY Change -37.47% 213.11% -51.59%
% of Gross Profit 46.33% 153.04% 40.03%
Depreciation & Amortization $690.0K $660.0K $870.0K
YoY Change -18.82% -24.14% 10.13%
% of Gross Profit 12.69% 26.44% 28.54%
Operating Expenses $7.304M $7.458M $4.703M
YoY Change 3.24% 58.58% 23.37%
Operating Profit -$6.944M -$10.66M -$6.707M
YoY Change -49.18% 58.98% -19.6%
Interest Expense $10.01M $3.020M $8.000K
YoY Change 130.11% 37650.0% -42.86%
% of Operating Profit
Other Income/Expense, Net $17.41M $5.778M -$11.34M
YoY Change 294.85% -150.93% 365.87%
Pretax Income $10.47M -$4.890M -$18.06M
YoY Change -213.19% -72.92% 67.38%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $10.47M -$4.885M -$18.06M
YoY Change -213.19% -72.95% 67.35%
Net Earnings / Revenue 95.29% -71.18% -279.25%
Basic Earnings Per Share $0.07 -$0.03 -$0.11
Diluted Earnings Per Share $0.07 -$0.03 -$0.11
COMMON SHARES
Basic Shares Outstanding 158.2M shares 158.0M shares 157.5M shares
Diluted Shares Outstanding 159.8M shares 158.1M shares 157.5M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $125.2M $99.70M $98.20M
YoY Change 41.15% 1.53% 23.68%
Cash & Equivalents $54.54M $35.59M $86.36M
Short-Term Investments $70.60M $64.10M $11.80M
Other Short-Term Assets $4.500M $4.300M $8.200M
YoY Change -51.09% -47.56% 446.67%
Inventory $29.81M $35.11M $30.36M
Prepaid Expenses $4.484M $4.312M $8.162M
Receivables $11.10M $2.400M $2.500M
Other Receivables $400.0K $500.0K $500.0K
Total Short-Term Assets $168.8M $139.9M $137.9M
YoY Change 32.86% 1.47% 23.94%
LONG-TERM ASSETS
Property, Plant & Equipment $20.21M $17.43M $21.52M
YoY Change -3.31% -19.0% -5.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $26.10M $17.40M $21.30M
YoY Change 13.97% -18.31% 1083.33%
Other Assets $19.70M $19.60M $22.10M
YoY Change -14.72% -11.31% -0.45%
Total Long-Term Assets $232.4M $232.1M $150.4M
YoY Change 52.85% 54.4% 14.85%
TOTAL ASSETS
Total Short-Term Assets $168.8M $139.9M $137.9M
Total Long-Term Assets $232.4M $232.1M $150.4M
Total Assets $401.2M $372.1M $288.3M
YoY Change 43.75% 29.08% 19.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.417M $1.585M $2.159M
YoY Change -46.04% -26.59% -32.53%
Accrued Expenses $4.500M $4.000M $1.400M
YoY Change 150.0% 185.71% 366.67%
Deferred Revenue $332.0K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.274M $5.569M $3.815M
YoY Change 33.8% 45.98% -69.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.60M $11.40M $13.90M
YoY Change -20.0% -17.99% 0.0%
Total Long-Term Liabilities $11.60M $11.40M $13.90M
YoY Change -20.0% -17.99% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.274M $5.569M $3.815M
Total Long-Term Liabilities $11.60M $11.40M $13.90M
Total Liabilities $17.87M $16.93M $17.74M
YoY Change -7.04% -4.58% -32.67%
SHAREHOLDERS EQUITY
Retained Earnings -$336.2M -$346.7M -$429.1M
YoY Change -23.29% -19.19% 2.28%
Common Stock $717.6M $699.9M $695.4M
YoY Change 2.98% 0.64% 10.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $379.5M $351.2M $266.6M
YoY Change
Total Liabilities & Shareholders Equity $401.2M $372.1M $288.3M
YoY Change 43.75% 29.08% 19.03%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income $10.47M -$4.885M -$18.06M
YoY Change -213.19% -72.95% 67.35%
Depreciation, Depletion And Amortization $690.0K $660.0K $870.0K
YoY Change -18.82% -24.14% 10.13%
Cash From Operating Activities -$6.910M -$1.380M -$10.81M
YoY Change -14.59% -87.23% 34.29%
INVESTING ACTIVITIES
Capital Expenditures $4.900M $6.060M $310.0K
YoY Change 824.53% 1854.84% 93.75%
Acquisitions
YoY Change
Other Investing Activities $14.42M -$350.0K -$11.44M
YoY Change -96.94% -928.99%
Cash From Investing Activities $9.520M -$6.410M -$11.74M
YoY Change -1896.23% -45.4% -1054.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 16.42M -530.0K 3.800M
YoY Change 23357.14% -113.95% -90.9%
NET CHANGE
Cash From Operating Activities -6.910M -1.380M -10.81M
Cash From Investing Activities 9.520M -6.410M -11.74M
Cash From Financing Activities 16.42M -530.0K 3.800M
Net Change In Cash 19.03M -8.320M -18.75M
YoY Change -322.57% -55.63% -153.65%
FREE CASH FLOW
Cash From Operating Activities -$6.910M -$1.380M -$10.81M
Capital Expenditures $4.900M $6.060M $310.0K
Free Cash Flow -$11.81M -$7.440M -$11.12M
YoY Change 37.01% -33.09% 35.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
295526000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-14730000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1766000 usd
CY2022Q1 efr Shares Issued For Cash By At The Market Offering
SharesIssuedForCashByAtTheMarketOffering
4260000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
96000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
862000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
328000 usd
CY2022Q1 us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
362350 shares
CY2022Q1 efr Stock Issued During Period Value Cash Paymentfor Tax Withholding
StockIssuedDuringPeriodValueCashPaymentforTaxWithholding
884000 usd
CY2022Q1 efr Adjustments To Additional Paid In Capital Shares Issued For Consulting Services
AdjustmentsToAdditionalPaidInCapitalSharesIssuedForConsultingServices
51000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
287083000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-18059000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3488000 usd
CY2022Q2 efr Shares Issued For Cash By At The Market Offering
SharesIssuedForCashByAtTheMarketOffering
3808000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
86000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1147000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
67000 usd
CY2022Q2 efr Adjustments To Additional Paid In Capital Shares Issued For Consulting Services
AdjustmentsToAdditionalPaidInCapitalSharesIssuedForConsultingServices
55000 usd
CY2022Q2 efr Stock Issued During Period Value Cash Paymentfor Tax Withholding
StockIssuedDuringPeriodValueCashPaymentforTaxWithholding
11000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
270516000 usd
us-gaap Net Income Loss
NetIncomeLoss
109379000 usd
us-gaap Net Income Loss
NetIncomeLoss
-32789000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1319000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1679000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2740000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2009000 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
620000 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
904000 usd
us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
0 usd
us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
445000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
325000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
1340000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-2189000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-16837000 usd
efr Miscellaneous Non Cash Income Expenses
MiscellaneousNonCashIncomeExpenses
76000 usd
efr Miscellaneous Non Cash Income Expenses
MiscellaneousNonCashIncomeExpenses
87000 usd
us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
335000 usd
us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
-172000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5515000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1784000 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
2373000 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
675000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1348000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
6594000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2269000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2987000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4069000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21358000 usd
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
5467000 usd
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
705000 usd
efr Purchase Of Mineral Properties
PurchaseOfMineralProperties
3055000 usd
efr Purchase Of Mineral Properties
PurchaseOfMineralProperties
0 usd
efr Acquisition Of Mineral Properties
AcquisitionOfMineralProperties
22374000 usd
efr Acquisition Of Mineral Properties
AcquisitionOfMineralProperties
0 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
67775000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
11435000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
16405000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
efr Disposal On Mineral Properties Investing Activities
DisposalOnMineralPropertiesInvestingActivities
56859000 usd
efr Disposal On Mineral Properties Investing Activities
DisposalOnMineralPropertiesInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25407000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12140000 usd
CY2022Q4 efr Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni Accumulated Gross Unrealized Loss Before Tax
DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax
2119000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7886000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
384000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
395000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1382000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7386000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-21000 usd
efr Release Of Restricted Cash
ReleaseOfRestrictedCash
-3590000 usd
efr Release Of Restricted Cash
ReleaseOfRestrictedCash
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-27218000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-26133000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80269000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
132822000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53051000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106689000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
106000 usd
efr Noncash Acquisition Of Convertible Note
NoncashAcquisitionOfConvertibleNote
59259000 usd
efr Noncash Acquisition Of Convertible Note
NoncashAcquisitionOfConvertibleNote
0 usd
us-gaap Interest Paid Net
InterestPaidNet
13000 usd
us-gaap Interest Paid Net
InterestPaidNet
17000 usd
efr Increase Decrease In Accrued Capital Expenditures And Accounts Payable For Property Plant And Equipment
IncreaseDecreaseInAccruedCapitalExpendituresAndAccountsPayableForPropertyPlantAndEquipment
734000 usd
efr Increase Decrease In Accrued Capital Expenditures And Accounts Payable For Property Plant And Equipment
IncreaseDecreaseInAccruedCapitalExpendituresAndAccountsPayableForPropertyPlantAndEquipment
-182000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
2876000 usd
CY2023Q2 efr Equity Securities Fvni Gross Unrealized Loss
EquitySecuritiesFVNIGrossUnrealizedLoss
1987000 usd
CY2023Q2 efr Equity Securities Fvni Gross Unrealized Gain
EquitySecuritiesFVNIGrossUnrealizedGain
0 usd
CY2023Q2 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
889000 usd
CY2023Q2 efr Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni Cost
DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNICost
125352000 usd
CY2023Q2 efr Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni Accumulated Gross Unrealized Loss Before Tax
DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax
2238000 usd
CY2023Q2 efr Total Marketable Securities
TotalMarketableSecurities
212000 usd
CY2023Q2 efr Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni
DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNI
123326000 usd
CY2022Q4 efr Debt Securities Fvni Cost
DebtSecuritiesFVNICost
11435000 usd
CY2022Q4 efr Debt Securities Fvni Gross Unrealized Loss
DebtSecuritiesFVNIGrossUnrealizedLoss
310000 usd
CY2022Q4 efr Debt Securities Fvni Gross Unrealized Gain
DebtSecuritiesFVNIGrossUnrealizedGain
0 usd
CY2022Q4 efr Debt Securities Fvni
DebtSecuritiesFVNI
11125000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
2876000 usd
CY2022Q4 efr Equity Securities Fvni Gross Unrealized Loss
EquitySecuritiesFVNIGrossUnrealizedLoss
1809000 usd
CY2022Q4 efr Equity Securities Fvni Gross Unrealized Gain
EquitySecuritiesFVNIGrossUnrealizedGain
0 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
1067000 usd
CY2022Q4 efr Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni Cost
DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNICost
14311000 usd
CY2022Q4 efr Total Marketable Securities
TotalMarketableSecurities
0 usd
CY2022Q4 efr Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni
DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNI
12192000 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
32978000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
35476000 usd
CY2023Q2 efr Inventory Of Ore In Stockpiles
InventoryOfOreInStockpiles
256000 usd
CY2022Q4 efr Inventory Of Ore In Stockpiles
InventoryOfOreInStockpiles
940000 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
1871000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4204000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
35105000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
40620000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
51920000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
34493000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17427000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
45836000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33174000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12662000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
660000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
870000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1320000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1680000 usd
CY2023Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
115715000 usd
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
83539000 usd
CY2023Q1 efr Number Of Purchase Agreements
NumberOfPurchaseAgreements
2 purchaseagreement
CY2023Q1 efr Purchase Agreement Acres To Purchase
PurchaseAgreementAcresToPurchase
37300 acre
CY2023Q1 efr Purchase Agreement Miles To Purchase
PurchaseAgreementMilesToPurchase
58.3 mi
CY2023Q1 efr Purchase Agreement Purchase Price
PurchaseAgreementPurchasePrice
27500000 usd
CY2023Q1 efr Purchase Agreement Deposit Payment
PurchaseAgreementDepositPayment
5900000 usd
CY2023Q1 efr Purchase Agreement Payment Due At Closing
PurchaseAgreementPaymentDueAtClosing
21600000 usd
CY2023Q1 efr Purchase Agreement Direct Deal Costs
PurchaseAgreementDirectDealCosts
1630000 usd
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
9595000 usd
CY2021Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
13687000 usd
us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
0 usd
CY2022 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
238000 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
620000 usd
CY2022 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1556000 usd
CY2023Q2 efr Asset Retirement Obligation Held For Sale
AssetRetirementObligationHeldForSale
0 usd
CY2022Q4 efr Asset Retirement Obligation Held For Sale
AssetRetirementObligationHeldForSale
5410000 usd
efr Asset Retirement Obligation Disposal Of Non Core Obligations
AssetRetirementObligationDisposalOfNonCoreObligations
79000 usd
CY2022 efr Asset Retirement Obligation Disposal Of Non Core Obligations
AssetRetirementObligationDisposalOfNonCoreObligations
0 usd
CY2023Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
10136000 usd
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
9595000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
17449000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
20305000 usd
efr Additional Collateral Posted
AdditionalCollateralPosted
10000 usd
CY2022 efr Additional Collateral Posted
AdditionalCollateralPosted
734000 usd
efr Restricted Cash And Cash Equivalents Held For Sale
RestrictedCashAndCashEquivalentsHeldForSale
0 usd
CY2022 efr Restricted Cash And Cash Equivalents Held For Sale
RestrictedCashAndCashEquivalentsHeldForSale
3590000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
17459000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
17449000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4861000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18054000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
109404000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-32783000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
158137420 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
157491807 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
158034370 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
157044331 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1156936 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
158137420 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157491807 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
159191306 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157044331 shares
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.03
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.11
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.69
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.21
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.03
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.11
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.69
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.21
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1500000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1550000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
310000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1520000 shares
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-18060000.00 usd
us-gaap Net Income Loss
NetIncomeLoss
-32790000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1554000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1147000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2740000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2009000 usd
efr Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisable Period
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePeriod
P5Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
767678 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.24
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
139211 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.12
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
106757 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.75
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
29747 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.79
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
7506 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
5.57
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
5.57
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
762879 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.74
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y10D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
2038000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
591144 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.82
efr Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term Instant
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermInstant
P1Y4M9D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2031000 usd
us-gaap Net Income Loss
NetIncomeLoss
109380000 usd
CY2023Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
8370000 usd
CY2023Q2 efr Change In Value Of Investments Accounted At Fair Value
ChangeInValueOfInvestmentsAccountedAtFairValue
770000 usd
CY2022Q2 efr Change In Value Of Investments Accounted At Fair Value
ChangeInValueOfInvestmentsAccountedAtFairValue
-13419000 usd
efr Change In Value Of Investments Accounted At Fair Value
ChangeInValueOfInvestmentsAccountedAtFairValue
-2189000 usd
efr Change In Value Of Investments Accounted At Fair Value
ChangeInValueOfInvestmentsAccountedAtFairValue
-16837000 usd
CY2023Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
10000 usd
CY2022Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-282000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
335000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-171000 usd
CY2023Q2 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
214000 usd
CY2022Q2 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
0 usd
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
214000 usd
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
0 usd
CY2023Q2 efr Debt Securities Convertible Note Unrealized Gain Loss
DebtSecuritiesConvertibleNoteUnrealizedGainLoss
-53000 usd
CY2022Q2 efr Debt Securities Convertible Note Unrealized Gain Loss
DebtSecuritiesConvertibleNoteUnrealizedGainLoss
0 usd
efr Debt Securities Convertible Note Unrealized Gain Loss
DebtSecuritiesConvertibleNoteUnrealizedGainLoss
-251000 usd
efr Debt Securities Convertible Note Unrealized Gain Loss
DebtSecuritiesConvertibleNoteUnrealizedGainLoss
0 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
293000 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2345000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
319000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1132000 usd
CY2023Q2 efr Component Of Other Income Expense
ComponentOfOtherIncomeExpense
1737000 usd
CY2022Q2 efr Component Of Other Income Expense
ComponentOfOtherIncomeExpense
4000 usd
efr Component Of Other Income Expense
ComponentOfOtherIncomeExpense
2762000 usd
efr Component Of Other Income Expense
ComponentOfOtherIncomeExpense
7000 usd
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2971000 usd
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-11352000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1190000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-15869000 usd
CY2023Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
2406000 usd
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
92000 usd
CY2023Q2 us-gaap Financing Receivable Accrued Interest After Allowance For Credit Loss
FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss
343000 usd
CY2022Q4 us-gaap Financing Receivable Accrued Interest After Allowance For Credit Loss
FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss
343000 usd
CY2023Q2 efr Accounts And Other Receivables Net
AccountsAndOtherReceivablesNet
181000 usd
CY2022Q4 efr Accounts And Other Receivables Net
AccountsAndOtherReceivablesNet
84000 usd
CY2023Q2 efr Receivables Net
ReceivablesNet
2930000 usd
CY2022Q4 efr Receivables Net
ReceivablesNet
519000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1585000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3224000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2121000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2929000 usd
CY2023Q2 efr Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
755000 usd
CY2022Q4 efr Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
22000 usd
CY2023Q2 efr Accrued Property Taxes Current
AccruedPropertyTaxesCurrent
392000 usd
CY2022Q4 efr Accrued Property Taxes Current
AccruedPropertyTaxesCurrent
240000 usd
CY2023Q2 efr Accrued Operating Expenses Current
AccruedOperatingExpensesCurrent
430000 usd
CY2022Q4 efr Accrued Operating Expenses Current
AccruedOperatingExpensesCurrent
409000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
166000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
105000 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5449000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6929000 usd
CY2023Q2 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
163935000 usd
CY2022Q4 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
61857000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
-251000 usd
efr Convertible Notes Increase Decrease In Fair Value
ConvertibleNotesIncreaseDecreaseInFairValue
-790000 usd
CY2023Q2 efr Change In Value Of Investments Accounted At Fair Value
ChangeInValueOfInvestmentsAccountedAtFairValue
770000 usd
CY2022Q2 efr Change In Value Of Investments Accounted At Fair Value
ChangeInValueOfInvestmentsAccountedAtFairValue
-13420000 usd
efr Change In Value Of Investments Accounted At Fair Value
ChangeInValueOfInvestmentsAccountedAtFairValue
-2190000 usd
efr Change In Value Of Investments Accounted At Fair Value
ChangeInValueOfInvestmentsAccountedAtFairValue
-16840000 usd
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001385849-23-000031-index-headers.html Edgar Link pending
0001385849-23-000031-index.html Edgar Link pending
0001385849-23-000031.txt Edgar Link pending
0001385849-23-000031-xbrl.zip Edgar Link pending
efr-20230630.htm Edgar Link pending
efr-20230630.xsd Edgar Link pending
efr-20230630_g1.jpg Edgar Link pending
efr-20230630_cal.xml Edgar Link unprocessable
efr06302023-exx231.htm Edgar Link pending
efr06302023-exx311.htm Edgar Link pending
efr06302023-exx312.htm Edgar Link pending
efr06302023-exx321.htm Edgar Link pending
efr06302023-exx322.htm Edgar Link pending
efr06302023-exx951.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
efr-20230630_htm.xml Edgar Link completed
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
efr-20230630_def.xml Edgar Link unprocessable
efr-20230630_pre.xml Edgar Link unprocessable
efr-20230630_lab.xml Edgar Link unprocessable